Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America — Dallas, Texas

Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America is a clinical research site located in Dallas, Texas, United States 75234.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America has participated in 1 clinical trials.

Therapeutic areas: Migraine, With or Without Aura.

Sponsors: Allergan.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America?

Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America conducted?

Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America has 1 clinical trials on record. Their work covers Migraine, With or Without Aura.

Is Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America accredited by Crixeo Health?

Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Synexus US, L.P. Formally known as Texas Pharmaceutical Research, LP, DBA Research Across America?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.